The Cannabis Connection 2025 will take place on November 6th, in São Paulo (SP), at the Anfiteatro da Av. Juscelino Kubitschek, 1600, Itaim Bibi. The event's theme is “The New Scenario of Cannabis and Hemp in Brazil: Advances, Challenges, and Opportunities” and will bring together experts, researchers, and professionals from the sector to discuss one of the most decisive moments for cannabis in the country.

Among the confirmed speakers are:

• Beatriz Marti Emygdio – Researcher at Embrapa and president of the Permanent Strategic Advisory Committee on Cannabis, a reference in hemp studies and industrial applications of the plant.

• Filipe Campos – Leader of Market Insights at Close-Up International, specialist in data analysis and trends in the pharmaceutical market, focusing on medicinal cannabis.

• Tarso Araujo – Journalist, documentarian, and consultant, working for years in health and drug policies, being one of the most respected voices in the public debate on cannabis in Brazil.

• João Paulo Silvério Perfeito – Clinical and industrial pharmacist, master in Health Sciences from the University of Brasília, with experience in formulations, regulation, and therapeutic use of cannabis.

   

Official Schedule

• 2:30 PM – Registration

• 3:00 PM – Sechat Retrospective

• 3:10 PM – Hemp Market Overview

• 3:30 PM – Cannabis in Brazil: Challenges and Prospects for Post-Regulation Cultivation

• 4:30 PM – Coffee Break

• 5:00 PM – Medicinal Cannabis Market Outlook from 2025 to 2026

• 6:00 PM – Advancements for the Regulation of Medicinal Cannabis in Brazil

• 7:00 PM – Cocktail and Networking

Learn more at www.cannabisconnection.com.br 

Regulatory Expectations for 2025

The event takes place in a year of high expectations for the sector. By September 30th, the federal government, as ordered by the STJ, must present regulations for cannabis cultivation for medicinal purposes and industrial hemp in Brazil. The measure could pave the way for national production, reduce costs, and expand access to patients.

Another front is the revision of RDC 327/2019, an Anvisa standard that regulates cannabis-based products in the country. The public consultation received over 1,500 contributions and discusses points such as new administration routes (sublingual, topical, and possibly inhalation), adjustments to THC limits, deadlines for clinical studies, labeling, and rules for importing inputs.

These changes can redefine the Brazilian market, which has already generated R$ 237.9 million in product sales at pharmacies by March 2025 and has over 52,000 doctors prescribing plant derivatives.

Strategic Forum

With this scenario, Cannabis Connection 2025 is expected to serve as a strategic forum for those closely following the future of cannabis in Brazil. The discussions should reflect the direction of regulations and provide a practical insight into how companies, healthcare professionals, and patients will be impacted by the new rules.